Course
VitiligoNon-CME
Emerging Therapeutic Options in Vitiligo Management
Explore the spectrum of vitiligo presentations and treatments in this course, with insights on current therapies and emerging targeted approaches.
Learn
Delve into dermatology diseases with new approaches from conventional to complementary care.
Topics
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Training Programs
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Conferences
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
Join Us
The largest integrative dermatology community.
John Harris, MD PhD
Biography
Dr. Harris is Chair of Dermatology, Director of the Autoimmune Therapeutics Institute, and Director of the Vitiligo Clinic and Research Center at UMass Chan Medical School. He is a dermatologist and physician-scientist, caring for patients in a vitiligo specialty clinic and running a research laboratory focused on understanding disease pathogenesis and developing new treatments. His group integrates basic, translational, and clinical research strategies to accomplish this. As a result, clinical trials in vitiligo have shown success. Dr. Harris founded Villaris Therapeutics (acquired by Incyte in 2022) and 4 other companies to develop treatments for inflammatory skin diseases.
Related Content
Micro Course
VitiligoNon-CME
Choosing Initial Treatment Options in a Patient with Vitiligo
Learn how to assess vitiligo disease activity and choose the best initial treatment through this case-based question.
Series
15 courses
Optimizing Clinical Decision-Making and Competence in JAK Inhibitor Therapy for Vitiligo
All material on this website is protected by copyright. Copyright © LearnHealth Inc. 2026.
This website also contains material copyrighted by 3rd parties.
SUBSCRIBE
To Get Posts Directly In Your Inbox!